News AMP

IPO News Today: Latest Market Listings and Top Debuts

Introduction The U.S. IPO market is showing renewed momentum as February 2026 unfolds. Several companies have already debuted, while a wave of high-profile listings looms on the horizon. This article delivers a clear snapshot of...

Introduction

The U.S. IPO market is showing renewed momentum as February 2026 unfolds. Several companies have already debuted, while a wave of high-profile listings looms on the horizon. This article delivers a clear snapshot of today’s IPO landscape, spotlighting recent listings, market trends, and what investors are watching next.

SpaceX weighs June 2026 IPO at $1.5 trillion valuation, FT says
byu/kex06 inwallstreetbets

Recent U.S. IPO Activity

Several companies have gone public in February, with mixed performance across sectors:

  • Forgent Power Solutions, Eikon Therapeutics, and Bob’s Discount Furniture launched earlier this month. Forgent raised $1.5 billion and ended its first trading day up 7%. Eikon fell 17% on debut, while Bob’s remained nearly flat.
  • According to a detailed IPO calendar, SharonAI Holdings (SHAZ) listed on February 19, raising $125 million at $30 per share and trading slightly above that level.
  • Other recent listings include SOLV Energy, which raised about $589 million and is trading well above its $25 IPO price, and ARKO Petroleum, which raised roughly $183 million.

These listings reflect a cautious but active IPO environment, with performance varying significantly by sector and company.

IPO Market Outlook: A Surge Ahead

Wall Street is bracing for a major rebound in IPO activity:

OpenAI preparing for fourth-quarter IPO in 2026
byu/Old-Competition3596 instocks

  • Goldman Sachs projects U.S. IPO proceeds could quadruple to a record $160 billion in 2026, with the number of deals potentially doubling to around 120.
  • This surge is expected to be driven by mega-cap tech and AI firms, including potential listings from SpaceX, OpenAI, and Anthropic.
  • However, analysts caution that volatility in software stocks and valuation pressures could temper issuance.

SPACs Still Leading the Charge

Special Purpose Acquisition Companies (SPACs) continue to dominate early 2026 IPO activity:

  • In January, SPACs accounted for 73% of all U.S. IPOs, raising $5.6 billion. There are currently 310 active SPACs holding around $46 billion in trust, with many more deals in the pipeline.

This trend underscores the continued appeal of SPACs as a faster route to public markets amid uncertain conditions.

Global and Index Impacts

Beyond the U.S., IPO activity is also heating up globally:

  • FTSE Russell has proposed a fast-entry mechanism for IPOs to ensure major new listings are incorporated into its U.S. equity indexes more swiftly.
  • In India, a robust pipeline is building with over 190 companies lining up to go public in 2026, aiming to raise more than ₹2.5 lakh crore. Major names include Reliance Jio, PhonePe, Flipkart, and Zepto.
  • Additionally, India faces a wave of IPO lock-in expiries between mid-February and late May, potentially unlocking $53 billion in shares and impacting market dynamics.

What Investors Are Watching Next

Looking ahead, several key developments will shape the IPO landscape:

  • Medline (MDLN), the largest U.S. IPO since 2021, has surged over 60% since its December debut. Its first earnings report is due February 25, and investors are watching closely.
  • The performance of upcoming mega-IPOs—especially from SpaceX, OpenAI, and Anthropic—will likely define investor sentiment and market momentum for the rest of the year.
  • Market volatility, particularly in software and AI sectors, remains a key risk that could delay or downsize planned listings.

Conclusion

The IPO market in early 2026 is a mix of cautious optimism and anticipation. Recent listings like Forgent and SharonAI show varied investor response, while SPACs continue to dominate activity. Goldman Sachs’ forecast of a record-breaking $160 billion in proceeds hinges on mega-IPOs from tech giants. Meanwhile, global markets—from FTSE index rules to India’s IPO pipeline—are adapting to a fast-evolving landscape. Investors now await earnings from Medline and the potential debut of high-profile tech firms, all while watching for signs of volatility that could reshape the IPO calendar.

Share:

You're reading the fast AMP version. View full article →